Indianapolis, IN, United States of America

Kumiko Takeuchi



 

Average Co-Inventor Count = 6.4

ph-index = 6

Forward Citations = 98(Granted Patents)


Company Filing History:


Years Active: 1995-2012

Loading Chart...
Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Kumiko Takeuchi in Pharmaceutical Patents

Introduction

Kumiko Takeuchi is a renowned inventor based in Indianapolis, IN, whose innovative contributions have significantly advanced the field of pharmaceuticals. With a remarkable portfolio of 28 patents, her work primarily focuses on developing novel compounds for treating various medical conditions, including diabetes and obesity.

Latest Patents

Among her latest patents, Kumiko has developed GPR119 agonist compounds designed to provide pharmaceutical compositions for the treatment of diabetes and obesity. Additionally, she has contributed to formulating 6-substituted nicotinamide derivatives that function as opioid receptor antagonists. These compounds showcase a formula that allows for various pharmaceutical applications and methods of use, reflecting her commitment to advancing medical science.

Career Highlights

Kumiko Takeuchi is currently employed at Eli Lilly and Company, where her research has been instrumental in developing cutting-edge pharmaceutical products. Her expertise and contributions have positioned her as a leading figure in innovation within the company and the wider scientific community.

Collaborations

Throughout her career, Kumiko has collaborated with esteemed colleagues such as Daniel Jon Sall and Richard Waltz Harper. These partnerships have fostered an environment of teamwork and innovation, allowing for the successful development of groundbreaking therapies.

Conclusion

Kumiko Takeuchi's impact in the pharmaceutical industry through her innovative patents and collaborations exemplifies her dedication to improving healthcare outcomes. Her ongoing efforts continue to pave the way for advancements in medical treatments, making her a key figure in the realm of pharmaceutical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…